Crossject Reports Positive Results From Bioequivalence Study With Needle Free ZENEO Methrotrexate

The needle-free injection with ZENEO® Methrotrexate produces similar blood levels to the current injectable formulation Study data an important milestone in the development of CROSSJECT’s portfolio of ZENEO® needle-free products November 24, 2014 CROSSJECT, the creator of ZENEO®, a needle free injection system, announces the similarity between the ZENEO® Methotrexate needle-free injection system and the current injectable formulation. ZENEO® Methotrexate …